1. Home
  2. MLGO vs CRVO Comparison

MLGO vs CRVO Comparison

Compare MLGO & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroAlgo Inc.

MLGO

MicroAlgo Inc.

HOLD

Current Price

$4.11

Market Cap

44.0M

Sector

Technology

ML Signal

HOLD

Logo CervoMed Inc.

CRVO

CervoMed Inc.

HOLD

Current Price

$3.93

Market Cap

35.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLGO
CRVO
Founded
2018
2001
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.0M
35.9M
IPO Year
2020
2011

Fundamental Metrics

Financial Performance
Metric
MLGO
CRVO
Price
$4.11
$3.93
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$23.00
AVG Volume (30 Days)
82.8K
33.5K
Earning Date
04-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$87,132,230.00
$4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.91
N/A
Revenue Growth
6.21
N/A
52 Week Low
$0.50
$3.51
52 Week High
$21.18
$13.13

Technical Indicators

Market Signals
Indicator
MLGO
CRVO
Relative Strength Index (RSI) 56.61 52.05
Support Level $3.20 $3.57
Resistance Level $4.47 $4.33
Average True Range (ATR) 0.27 0.23
MACD 0.01 0.03
Stochastic Oscillator 65.65 62.62

Price Performance

Historical Comparison
MLGO
CRVO

About MLGO MicroAlgo Inc.

MicroAlgo Inc is engaged in the development and application of bespoke central processing algorithms and provides solutions by integrating these algorithms with software or hardware, or both, to streamline digital services. Its services include algorithm optimization, accelerating computing power without hardware upgrades, lightweight data processing, and data intelligence services. Its technology and solutions are mainly in internet multimedia video advertising, where it provides advertising distribution solutions, software services, comprehensive solutions for enterprise customers, and intelligent chips solutions. It derives revenue from central processing algorithm services for internet advertisement and intelligent chips and services, with maximum revenue generated from Mainland PRC.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: